nnng.com› Comparisons› BPC-157 vs TB-500
🩹

BPC-157 vs TB-500

The two peptides most often marketed for injury recovery, compared on what is actually known: human evidence, regulatory status and risks.

✓ Written by Derek Giordano, Founder & Editor · Last reviewed October 8, 2026 · Medical disclaimer
BPC-157
Body Protection Compound-157
VS
TB-500
Thymosin beta-4 fragment
FactorBPC-157TB-500
What it isSynthetic 15-amino-acid peptide based on a gastric juice proteinSynthetic fragment modeled on thymosin beta-4, an actin-binding protein
Human evidenceVery limited; mostly rodent studies, a few small human reportsEssentially none for TB-500; the full parent protein has had small human trials
FDA approvalNot approvedNot approved
Compounding status (Oct 2026)Advisory committee recommended listing 8–6 in July 2026; FDA decision pendingAdvisory committee recommended listing 8–6 in July 2026; FDA decision pending
SportProhibited (WADA)Prohibited (WADA)
Main concernsUnregulated purity; immunogenicity and impurity concerns FDA raised in 2023Unregulated purity; open questions about effects on cell growth
Established human doseNoneNone

⚖️ The verdict

Neither compound has the human trial evidence needed to say it works for injuries, or which works better. Claims that one is "excellent" for tendons or muscle come from animal studies. Their regulatory paths are identical: both were recommended for the compounding list by an advisory committee in July 2026, and neither had been finalized by FDA as of October 2026. Anyone weighing either one should start with a clinician and treatments that have human evidence behind them.

Why there are no doses on this page

Neither compound has an established human dose. Figures in seller protocols are extrapolated from animal studies, so nnng.com does not repeat them. Full profiles: BPC-157 · TB-500.

Frequently asked questions

Which is better for injuries, BPC-157 or TB-500?
There is no human trial comparing them, and neither has strong human evidence on its own. Rankings online come from animal studies and anecdote.
Can BPC-157 and TB-500 be taken together?
Combining them is common in seller protocols, but no human study has tested the combination for safety or benefit.
Are BPC-157 and TB-500 legal?
Neither is FDA-approved. Both were recommended for the compounding list in July 2026; FDA had not finalized that as of October 2026.